Pharmacokinetics of Oral Hydroxyurea Solution
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 20
Summary
- Conditions
- Sickle Cell Disease
- Sickle Cell Hemoglobin C
- Sickle Cell-beta-thalassemia
- Sickle-Cell; Hemoglobin Disease, Thalassemia
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 617 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03763656
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Angela E Rankine- Mullings, MD University of the West Indies, Mona, Kingston, Jamaica
Get Well Soon